Pahuja S L, Hochberg R B
Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut 06510.
Endocrinology. 1995 Jan;136(1):180-6. doi: 10.1210/endo.136.1.7828529.
Although fatty acid esters of several steroids have been found in both blood and tissues, their biosynthetic origins are uncertain. For example, the fatty acid esters of delta 5-3 beta-hydroxysteroids pregnenolone and dehydroepiandrosterone (DHEA) are synthesized in tissues by an acyl coenzyme A:acyltransferase. These esters are not secreted, and the circulating esters are formed in blood by lecithin:cholesterol acyltransferase (LCAT). Fatty acid esters of corticosterone (B) and estradiol (E2) are also present in both blood and tissues, but unlike the delta 5-3 beta-hydroxysteroids, their structures are so different from cholesterol that it would not necessarily follow that they are esterified by the same enzyme. We have examined the esterification of the steroids DHEA, B, and E2 in blood and tissue, in comparison to the esterification of cholesterol, using as a model plasma and hepatic microsomes from the rat. All of the steroids were esterified in plasma, but at very different rates: cholesterol > DHEA >> E2 = B. The LCAT inhibitor, 5.5'-dithiobis-(2-nitrobenzoic acid), inhibited the esterification of all of the substrates. DHEA inhibited the esterification of cholesterol, albeit only at high concentration. The fatty acid compositions of the cholesterol and DHEA esters were analyzed, and they were found to be identical, with arachidonate the predominant ester, greater than 60%. In hepatic microsomes, the rate of esterification was different than plasma: cholesterol > E2 > or = DHEA >> B. Although B was esterified in both plasma and hepatic microsomes, the rate was exceedingly slow in both. The acyl coenzyme A:cholesterol acyltransferase inhibitor, N'-(2,4-difluorophenyl)-N-[[4-(2,2-dimethylpropyl)phenyl]- methyl]-N-heptylurea, blocked the esterification of cholesterol almost completely, but surprisingly, it had no effect on the esterification of the other steroids. The fatty acid esters of cholesterol, E2, and DHEA synthesized in the hepatic microsomes were analyzed. The composition of the cholesterol esters from the microsomes was very different than the esters of DHEA and E2. These results show that all of the steroids tested are esterified by LCAT, and consequently that blood LCAT is the probable source of the circulating steroidal esters. Most interesting are the studies of microsomal esterification. It has been presumed that similar to blood, the esterification of steroids in tissues is carried out by the same enzyme that esterifies cholesterol.(ABSTRACT TRUNCATED AT 400 WORDS)
尽管在血液和组织中都发现了几种类固醇的脂肪酸酯,但其生物合成来源尚不确定。例如,δ5-3β-羟基类固醇孕烯醇酮和脱氢表雄酮(DHEA)的脂肪酸酯是在组织中由酰基辅酶A:酰基转移酶合成的。这些酯不会分泌,而循环中的酯是由卵磷脂:胆固醇酰基转移酶(LCAT)在血液中形成的。皮质酮(B)和雌二醇(E2)的脂肪酸酯也存在于血液和组织中,但与δ5-3β-羟基类固醇不同,它们的结构与胆固醇差异很大,因此不一定是由同一种酶酯化的。我们以大鼠的血浆和肝微粒体为模型,研究了类固醇DHEA、B和E2在血液和组织中的酯化情况,并与胆固醇的酯化情况进行了比较。所有类固醇在血浆中都能被酯化,但速率差异很大:胆固醇>DHEA>>E2 = B。LCAT抑制剂5,5'-二硫代双(2-硝基苯甲酸)抑制了所有底物的酯化。DHEA抑制胆固醇的酯化,尽管仅在高浓度时才有此作用。分析了胆固醇和DHEA酯的脂肪酸组成,发现它们相同,花生四烯酸是主要酯类,含量超过60%。在肝微粒体中,酯化速率与血浆不同:胆固醇>E2≥DHEA>>B。尽管B在血浆和肝微粒体中都能被酯化,但在两者中的速率都非常慢。酰基辅酶A:胆固醇酰基转移酶抑制剂N'-(2,4-二氟苯基)-N-[[4-(2,2-二甲基丙基)苯基]甲基]-N-庚基脲几乎完全阻断了胆固醇的酯化,但令人惊讶的是,它对其他类固醇的酯化没有影响。分析了在肝微粒体中合成的胆固醇、E2和DHEA的脂肪酸酯。微粒体中胆固醇酯的组成与DHEA和E2的酯有很大不同。这些结果表明,所有测试的类固醇都是由LCAT酯化的,因此血液中的LCAT可能是循环类固醇酯的来源。最有趣的是微粒体酯化的研究。据推测,与血液类似,组织中类固醇的酯化是由酯化胆固醇的同一种酶进行的。(摘要截取自400字)